Role of protease inhibition in myocardial preservation in prolonged hypothermic cardioplegia followed by reperfusion. Effect of aprotinin in an experimental model

Journal of Thoracic and Cardiovascular Surgery

Volumn 96, Issue 2, 1988, Pages 314-320

  Sunamori, M ^a   Innami, R ^a   Amano, J ^a   Suzuki, A ^a   Harrison, C E ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ASPARTATE AMINOTRANSFERASE; BETAMETHASONE; CYCLIC GMP; N ACETYL BETA GLUCOSAMINIDASE; NIFEDIPINE; UBIQUINONE;

ANIMAL EXPERIMENT; CARDIOPLEGIA; DOG; EXTRACORPOREAL CIRCULATION; HEART MUSCLE METABOLISM; HEART MUSCLE PRESERVATION; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0023790103     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5223(19)35278-x     Document Type: Article

References (34)

1. Wildenthal K Lysosomal alterations in ischemic myocardium: result or cause of myocellular damage? (Editorial) J Mol Cell Cardiol 10 1978 595 603
2. Decker RS Wildenthal K Sequential lysosomal alterations during cardiac ischemia. II. Ultrastructural and cytochemical changes Lab Invest 38 1978 662 673
3. Fox AC Hoffstein S Weissmann G Lysosomal mechanisms in production of tissue damage during myocardial ischemia and the effects of treatment with steroids Am Heart J 91 1976 394 397
4. Cornblath M Randle PJ Parmeggiani A Morgan HE Regulation of glycogenolysis in muscle: effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart J Biol Chem 238 1963 1592 1597
5. Case RB Ion alterations during myocardial ischemia Cardiology 56 1971 245 262
6. Wollenberger A Shahab L Anoxia-induced release of noradrenaline from the isolated perfused heart Nature 207 1965 88 89
7. Wollenberger A Krause E-G Metabolic control characteristics of the acutely ischemic myocardium Am J Cardiol 22 1968 349 359
8. Ogletree ML Lefer AM Influence of nonsteroidal antiinflammatory agents on myocardial ischemia in the cat J Pharmacol Exp Ther 197 1976 582 593
9. Jennings RB Relationship of acute ischemia to functional defects and irreversibility Circulation 53 Pt 2 1976 126 129
10. Busuttil RW George WJ Myocardial ischemia, cyclic nucleotides, and lysosomal enzymes Adv Cyclic Nucleotide Res 9 1978 629 645
11. Carr FK Goldfarb RD Ischemia-induced canine myocardial lysosome labilization: the role of endogenous prostaglandins and cyclic nucleotides Exp Mol Pathol 33 1980 36 42
12. Ignarro LJ Krassikoff N Slywka J Release of enzymes from a rat liver lysosome fraction: inhibition by catecholamines and cyclic 3′,5′-adenosine monophosphate, stimulation by cholinergic agents and cyclic 3′,5′-guanosine monophosphate J Pharmacol Exp Ther 186 1973 86 99
13. Sunamori M Amano J Okamura T Suzuki A Superior action of magnesium-lidocaine-1-aspartate cardioplegia to glucose-insulin-potassium cardioplegia in experimental myocardial protection Jpn J Surg 12 1982 372 380
14. Yokoyama M The effect of pharmacological pretreatment on the long-term globally ischemic heart: lysosome, cyclic nucleotide and myocardial injury J Jpn Surg Soc 88 1987 109 118
15. Clark RE Christlieb IY Henry PD Nifedipine: a myocardial protective agent Am J Cardiol 44 1979 825 831
16. Sunamori M Harrison CE Jr Effect of betamethasone on mitochondrial oxidative phosphorylation in ischemic canine myocardium Mayo Clin Proc 55 1980 377 382
17. Sunamori M Protective effect of betamethasone on the subendocardial ischemia after the cardiopulmonary bypass J Cardiovasc Surg (Torino) 19 1978 291 310
18. 10 in reperfused ischemic myocardium Jpn Ann Thorac Surg 2 1982 827 834
19. 10 to protect ischemic heart muscle Yamamura Y Folkers K Ito Y Biomedical and clinical aspects of coenzyme Q 2 1980 Elsevier Science Publishers Amsterdam 409 425
20. 10 in surgery 1983 Ishiyaku-Shuppan Tokyo 1 17
21. Sunamori M Amano J Kameda T Okamura T Ozeki M Suzuki A Additive protection of aprotinin, protease inhibitor to cold cardioplegia from ischemic myocardium Jpn Circ J 44 1980 771 775
22. Sunamori M Tanaka H Okamura T Pharmacological myocardial protection in addition to cold cardioplegia in coronary artery revascularization: effect of protease-inhibitor on intraoperative myocardial protection Dudziak R Reuter HD Kirchhoff PG Schumann F Proteolyse und Proteinaseninhibition in der Herz- und Gefaesschirurgie 1985 Schattauer Stuttgart 281 288
23. Davis H Gascho C Kiernan JA Effects of aprotinin on organ cultures of the rat’s kidney In Vitro 12 1976 192 197
24. Davis H Gascho C Kiernan JA Action of aprotinin on the survival of adult cerebellar neurons in organ culture Acta Neuropathol (Berl) 32 1975 359 362
25. Guthrie R Rizzi GT McCabe RE Jr Experimental study of the effect of a proteinase inhibitor (Trasylol) on organ preservation Am J Surg 112 1966 835 838
26. Godfrey AM Salaman JR Trasylol (aprotinin) and kidney preservation Transplantation 25 1978 167 168
27. Hoyer J Garbe L Delpierre S Prieur A Macquart-Moulin G Noirclerc M Functional evaluation of the transplanted lung after long-term preservation Respiration 39 1980 323 332
28. 2-antiplasmin Thromb Res 17 1980 143 152
29. Balldin G Ohlsson K Demonstration of pancreatic proteaseantiprotease complexes in the peritoneal fluid of patients with acute pancreatitis Surgery 85 1979 451 456
30. Glenn TM Tauber PF Miller AG Golfarb RD Mustafa SJ Alterations of the hemodynamic and biochemical sequelae associated with acute coronary ligation by aprotinin Cantin M Haberland GL Schnells G Selye H New aspects of trasylol therapy 8 1975 Schattauer Stuttgart 329 345
31. Nagaoka H Katori M Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery Circulation 52 1975 325 332
32. Mustafa SJ Effect of aprotinin on the metabolism of adenosine in cultured heart cells Biochem Pharmacol 28 1979 340 343
33. Abell CW Monahan TM The role of adenosine 3′,5′-cyclic monophosphate in the regulation of mammalian cell division J Cell Biol 59 1973 549 558
34. Katoh K The effect of chemical mediators (bradykinin, histamine) on cyclic AMP levels of murine lymphocytes subpopulation J Nippon Med Sch 46 1979 234 240